Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality
NCT01024114 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2012-04-18
Summary
The purpose of this pilot study is to investigate the potential clinical benefits of combining two new diagnostic tools to provide co-registered anatomical and functional information in the breast in patients with suspected breast cancer.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Michael K. O'Connor, Ph.D · Mayo Clinic
Eligibility
- Min Age
- 25 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2012-12-31
Countries
- United States
Study Locations
More Related Trials
-
Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation
NCT00591864 ·Status: COMPLETED ·Phase: NA
-
Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up
NCT01723124 ·Status: TERMINATED ·Phase: NA
-
Use of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions
NCT01285440 ·Status: COMPLETED
-
Screening in Myocardial Perfusion Patients
NCT00943241 ·Status: COMPLETED
-
Histology of Functional Density in Postmenopausal Breast
NCT01240278 ·Status: COMPLETED
-
Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study
NCT01433640 ·Status: COMPLETED
-
Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
NCT00620373 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients
NCT02024074 ·Status: TERMINATED ·Phase: PHASE1
-
Molecular Imaging of Breast Cancer With Breast PET/CT
NCT00584753 ·Status: TERMINATED ·Phase: PHASE1
-
Pre-biopsy With Dynamic Acquisitions
NCT00943644 ·Status: COMPLETED
-
Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)
NCT00890994 ·Status: COMPLETED
-
Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy
NCT00580086 ·Status: COMPLETED
-
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
NCT01653964 ·Status: COMPLETED ·Phase: NA
-
Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy
NCT05301790 ·Status: UNKNOWN
-
Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging
NCT01027767 ·Status: COMPLETED
-
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
NCT05042687 ·Status: RECRUITING ·Phase: NA
-
Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy
NCT01568346 ·Status: TERMINATED ·Phase: PHASE3
-
Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue
NCT03220893 ·Status: COMPLETED ·Phase: NA
-
Contrast-enhanced MR Imaging as a Breast Cancer Screening in Women at Intermediate Risk
NCT02210546 ·Status: UNKNOWN ·Phase: NA
-
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions
NCT05754749 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
NCT07207564 ·Status: RECRUITING
-
Magnetic Resonance Imaging in Radiotherapy for Breast Cancer
NCT05902507 ·Status: SUSPENDED
-
18F-FLT Positron Emission Tomography and Magnetic Resonance Imaging of the Breast
NCT01956890 ·Status: UNKNOWN ·Phase: PHASE4
-
Cone Beam Computed Tomography for Breast Imaging
NCT00972413 ·Status: COMPLETED ·Phase: PHASE1
-
Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma
NCT00291304 ·Status: TERMINATED ·Phase: PHASE2